Key terms
About NBY
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NBY news
Yesterday
7:02am ET
NovaBay sees Q1 revenue $2.6M, up 13% from last year
Apr 15
5:16am ET
Buy Rating Maintained for NovaBay Pharma Amid Strategic Refocus and Resilient Revenue Performance
Apr 03
7:05am ET
NovaBay price target lowered to $3.20 from $3.80 at Ladenburg
Mar 13
7:28am ET
NovaBay, Eyenovia to co-promote prescription ophthalmic products
Feb 01
11:24am ET
Biotech Alert: Searches spiking for these stocks today
Jan 31
10:56am ET
Biotech Alert: Searches spiking for these stocks today
No recent press releases are available for NBY
NBY Financials
Key terms
Ad Feedback
NBY Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NBY Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range